19-nor-Doxercalciferol(131918-62-2)
- Name: 19-nor-Doxercalciferol
- Synonyms:19-nor-Doxercalciferol;1,3-Cyclohexanediol, 5-[(2E)-2-[(1R,3aS,7aR)-octahydro-7a-methyl-1-[(1R,2E,4R)-1,4,5-trimethyl-2-hexen-1-yl]-4H-inden-4-ylidene]ethylidene]-, (1R,3R)-;(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol
- Molecular Formula:C27H44O2
- Molecular Weight:400.64
- CAS Registry Number:131918-62-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.131918-62-2 19-Nor-doxercalciferol
Assay:98%Min Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by ocean shipping or clients requirement Application:An important raw material and intermediate used in Organic Synthesis, Pharmaceuticals
Min. Order:0
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)] CAS No.131918-62-2 19-nor-Doxercalciferol
Assay:98% Package:According to your demand Transportation:as requested
Min. Order:0Metric Ton
Supplier:Chemvon Biotechnology Co. Ltd. [
China (Mainland)] CAS No.131918-62-2 19-nor-Doxercalciferol
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:19-nor-Doxercalciferol
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 308145-19-9/2-Butene-1,4-diamine, N,N'-bis[3-(ethylamino)propyl]-, (2Z)-
- 875756-97-1/bisBenziMide H 33342 trihydrochloride
- 1269815-17-9/Piperidine-3-carboxylic acid [5-chloro-4-(5-fluoro-2-methoxy-phenyl)-pyridin-2-yl]-amide
- 1218779-75-9/N-[4-(1-Cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide methanesulfonate
- 445493-23-2/11107B
- 1177489-18-7/CASPASE-13 INHIBITOR I
- 1142214-62-7/AM-1638
- 4727-31-5/Kartogenin
- 195883-07-9/YM 273
- 865784-01-6/ON 013105
- 857070-65-6/1-((3-hydroxy-6-Methylpyridin-2-yl)Methyl)-2-((3-Morpholinopropyl)aMino)-1H-benzo[d]iMidazole-6-carbaldehyde
- 857067-38-0/2-((6-(hydroxyMethyl)-2-((3-Morpholinopropyl)aMino)-1H-benzo[d]iMidazol-1-yl)Methyl)-6-Methylpyridin-3-ol
- 245414-50-0/3-(((2R,3R)-4-((3S,4aS,8aS)-3-(tert-butylcarbaMoyl)octahydroisoquinolin-2(1H)-yl)-3-hydroxy-1-(phenylthio)butan-2-yl)carbaMoyl)-2-Methylphenyl acetate
- 857071-75-1/(E)-3-(4-Methyl-2-nitrophenyl)prop-2-en-1-ol
- 662151-10-2/ML-220
- 1354792-97-4/NI-07
- 1005780-62-0/TAK-593
- 926291-77-2/Benzeneethanol, β-aMino-3-chloro-, (βR)-
- 1286739-19-2/6-(2-Chloro-4-thiazol-5-yl-phenyl)-8-ethyl-2-[4-(4-Methyl-piperazin-1-yl)-phenylaMino]-8H-pyrido[2,3-d]pyriMidin-7-one
- 131918-62-2/19-nor-Doxercalciferol
- 1260907-17-2/GSK 525762A
- 333352-59-3/NBD-557
- 1096708-71-2/6-Amino-5-chloro-N-[(1R)-1-[5-[[[5-chloro-4-(trifluoromethyl)-2-pyridinyl]amino]carbonyl]-2-thiazolyl]ethyl]-4-pyrimidinecarboxamide
- 914462-92-3/Rolapitant hydrochloride
- 916151-99-0/LOR 253
- 929721-98-2/Impurity A of Maxacalcitol
- 1217835-38-5/(R)-(2,3-dimethyl-3-((trimethylsilyl)oxy)butyl)diphenylphosphine oxide
- 87407-51-0/(S)-2-((1R,3aS,7aR,E)-4-((E)-2-((S)-5-((tert-butyldiMethylsilyl)oxy)-2-Methylenecyclohexylidene)ethylidene)-7a-Methyloctahydro-1H-inden-1-yl)propan-1-ol
- 112875-61-3/(1S,4R,E)-4-((1R,3aS,7aR,E)-4-((Z)-2-((3S,5R)-3,5-bis((tert-butyldiMethylsilyl)oxy)-2-Methylenecyclohexylidene)ethylidene)-7a-Methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol
- 333353-44-9/NBD-556